Dirk Schepmann

3.9k total citations
205 papers, 3.4k citations indexed

About

Dirk Schepmann is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dirk Schepmann has authored 205 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Molecular Biology, 112 papers in Organic Chemistry and 84 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dirk Schepmann's work include Pharmacological Receptor Mechanisms and Effects (166 papers), Phenothiazines and Benzothiazines Synthesis and Activities (54 papers) and Receptor Mechanisms and Signaling (51 papers). Dirk Schepmann is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (166 papers), Phenothiazines and Benzothiazines Synthesis and Activities (54 papers) and Receptor Mechanisms and Signaling (51 papers). Dirk Schepmann collaborates with scholars based in Germany, Italy and Switzerland. Dirk Schepmann's co-authors include Bernhard Wünsch, Bastian Frehland, Kirstin Lehmkuhl, Roland Fröhlich, Peter Brust, Thomas Winckler, Christian Wiese, Erik Laurini, Sabrina Pricl and Kenichiro Itami and has published in prestigious journals such as Biochemistry, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Dirk Schepmann

200 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Schepmann Germany 31 2.4k 1.6k 1.2k 293 151 205 3.4k
Shaun R. Stauffer United States 35 1.9k 0.8× 1.4k 0.9× 1.1k 0.9× 249 0.8× 566 3.7× 96 4.2k
José Brea Spain 30 1.6k 0.7× 947 0.6× 655 0.6× 366 1.2× 393 2.6× 176 3.2k
Anna L. Blobaum United States 29 1.2k 0.5× 691 0.4× 888 0.8× 579 2.0× 172 1.1× 97 2.6k
John E. Macor United States 29 1.3k 0.5× 1.5k 1.0× 691 0.6× 395 1.3× 201 1.3× 161 3.2k
Michael R. Wood United States 28 1.4k 0.6× 797 0.5× 850 0.7× 263 0.9× 141 0.9× 79 2.4k
Klaus T. Wanner Germany 27 1.3k 0.5× 1.1k 0.7× 808 0.7× 199 0.7× 137 0.9× 197 2.6k
Roberto Perrone Italy 36 2.4k 1.0× 1.0k 0.7× 1.1k 0.9× 183 0.6× 212 1.4× 144 3.6k
Francesco Berardi Italy 39 2.7k 1.1× 1.1k 0.7× 1.2k 1.1× 194 0.7× 243 1.6× 153 3.9k
S. Wayne Mascarella United States 25 1.8k 0.7× 626 0.4× 1.4k 1.2× 287 1.0× 171 1.1× 98 2.7k
Mojgan Aghazadeh Tabrizi Italy 37 1.8k 0.7× 1.9k 1.2× 469 0.4× 430 1.5× 119 0.8× 104 4.0k

Countries citing papers authored by Dirk Schepmann

Since Specialization
Citations

This map shows the geographic impact of Dirk Schepmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Schepmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Schepmann more than expected).

Fields of papers citing papers by Dirk Schepmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Schepmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Schepmann. The network helps show where Dirk Schepmann may publish in the future.

Co-authorship network of co-authors of Dirk Schepmann

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Schepmann. A scholar is included among the top collaborators of Dirk Schepmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Schepmann. Dirk Schepmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Schepmann, Dirk, et al.. (2024). Synthesis and structure-affinity relationships of spirocyclic σ1 receptor ligands with tetrahydropyran scaffold. European Journal of Medicinal Chemistry. 281. 117002–117002.
3.
Schreiber, Julian A., Judith Schmidt, Bastian Frehland, et al.. (2024). Enantiomerically Pure Indazole Bioisosteres of Ifenprodil and Ro 25-6981 as Negative Allosteric Modulators of NMDA Receptors with the GluN2B Subunit. Journal of Medicinal Chemistry. 67(21). 19678–19688. 1 indexed citations
4.
Schepmann, Dirk, et al.. (2024). Quinolone bioisosteres of phenolic GluN2B‐selective NMDA receptor antagonists. Archiv der Pharmazie. 357(9). e2400279–e2400279. 1 indexed citations
5.
Ritter, Nadine, Julian A. Schreiber, Christoph Brenker, et al.. (2023). Downstream Allosteric Modulation of NMDA Receptors by 3-Benzazepine Derivatives. Molecular Neurobiology. 60(12). 7238–7252. 1 indexed citations
6.
Ritter, Nadine, Julian A. Schreiber, Judith Schmidt, et al.. (2023). Indazole as a Phenol Bioisostere: Structure–Affinity Relationships of GluN2B-Selective NMDA Receptor Antagonists. Journal of Medicinal Chemistry. 66(16). 11573–11588. 8 indexed citations
7.
Schmidt, Judith, Dirk Schepmann, Nadine Ritter, et al.. (2023). Negative allosteric modulators of NMDA receptors with GluN2B subunit: synthesis of β-aminoalcohols by epoxide opening and subsequent rearrangement. Organic & Biomolecular Chemistry. 21(37). 7616–7638.
8.
Schreiber, Julian A., Bastian Frehland, Dirk Schepmann, et al.. (2022). Phenol‐benzoxazolone bioisosteres of GluN2B‐NMDA receptor antagonists: Unexpected rearrangement during reductive alkylation with phenylcyclohexanone. Archiv der Pharmazie. 355(11). e2200225–e2200225. 3 indexed citations
9.
Schreiber, Julian A., et al.. (2022). Phenol—Benzoxazolone bioisosteres: Synthesis and biological evaluation of tricyclic GluN2B‐selective N‐methyl‐d‐aspartate receptor antagonists. Archiv der Pharmazie. 355(9). e2200147–e2200147. 3 indexed citations
10.
Schreiber, Julian A., Nadine Ritter, Dirk Schepmann, et al.. (2022). Synthesis of tropane-based σ1 receptor antagonists with antiallodynic activity. European Journal of Medicinal Chemistry. 230. 114113–114113. 8 indexed citations
11.
Civenni, Gianluca, Domenico Marson, Erik Laurini, et al.. (2021). Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σ1 receptor affinity, antitumor and analgesic activity. European Journal of Medicinal Chemistry. 219. 113443–113443. 12 indexed citations
12.
Cifani, Carlo, Emanuela Micioni Di Bonaventura, Fabio Del Bello, et al.. (2020). Novel Highly Potent and Selective Sigma1 Receptor Antagonists Effectively Block the Binge Eating Episode in Female Rats. ACS Chemical Neuroscience. 11(19). 3107–3116. 16 indexed citations
13.
Wagner, Stefan, Natalia V. Ortiz Zacarı́as, Annelien J.M. Zweemer, et al.. (2020). Development of the First Potential Nonpeptidic Positron Emission Tomography Tracer for the Imaging of CCR2 Receptors. ChemMedChem. 16(4). 640–645. 7 indexed citations
14.
Lehmkuhl, Kirstin, Kristina Friedland, Gianluca Civenni, et al.. (2020). Novel σ1 antagonists designed for tumor therapy: Structure – activity relationships of aminoethyl substituted cyclohexanes. European Journal of Medicinal Chemistry. 210. 112950–112950. 8 indexed citations
15.
Bello, Fabio Del, Maria Vittoria Micioni Di Bonaventura, Alessandro Bonifazi, et al.. (2019). Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane. ACS Chemical Neuroscience. 10(8). 3391–3397. 8 indexed citations
16.
Rossino, Giacomo, Julio Caballero, Dirk Schepmann, et al.. (2019). New Insights into the Opening of the Occluded Ligand-Binding Pocket of Sigma1 Receptor: Binding of a Novel Bivalent RC-33 Derivative. Journal of Chemical Information and Modeling. 60(2). 756–765. 11 indexed citations
17.
Schreiber, Julian A., Sebastian Müller, Dirk Schepmann, et al.. (2018). Systematic variation of the benzoylhydrazine moiety of the GluN2A selective NMDA receptor antagonist TCN-201. European Journal of Medicinal Chemistry. 158. 259–269. 12 indexed citations
18.
Müller, Christoph, et al.. (2017). Chiral-pool synthesis of 1,2,4-trisubstituted 1,4-diazepanes as novel σ1 receptor ligands. Bioorganic & Medicinal Chemistry. 25(17). 4778–4799. 5 indexed citations
19.
Müller, Steffen, Bernd T. Wolfstädter, Susanne Wolfrum, et al.. (2017). Oxetanyl Amino Acids for Peptidomimetics. Organic Letters. 19(10). 2510–2513. 33 indexed citations
20.
Schepmann, Dirk, et al.. (2011). Characterization of Ligand Binding to the σ 1 Receptor in a Human Tumor Cell Line (RPMI 8226) and Establishment of a Competitive Receptor Binding Assay. Assay and Drug Development Technologies. 10(4). 365–374. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026